A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis’ entire stake of around 70% in bulk-drugs maker Symbiotec Pharmalab Pvt. Ltd.

— VCCircle

L&L Partners advised Symbiotec Pharma Lab Pvt Limited led by a team of partner William Vivian John along with managing associate Deepak Kumar and associate Tanaya Sanyal.

Update 29 May 2019: A Platinum Partners team of partner Gautam Bhat and partner Abhik Ghosh for advised Actis Private Equity, and a team of partner Ankit Majmudar and associate Aayush Kumar for InvAscent.

Wadia Ghandy advised MOPE Investment Advisors Private Limited.

2018-12-18

Deal value: USD 100 million

{incomplete}